Adverse event [GxP / QC / QA]

posted by kiranActimus – India, 2009-08-14 12:14 (5753 d 01:56 ago) – Posting: # 4048
Views: 5,598

Dear Bhavesh

According to ICH GCP Any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. An adverse event (AE) can therefore be any unfavourable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal (investigational) product, whether or not related to the medicinal (investigational) product.

May be as u said the abnormality in the lab investigations is not because of the drug concentration we shall treat it as an adverse event only.

There are so many reasons for the change in the lab investigations other than the drug effect. It may be due to changes in the dietary habits etc.,

From the available literature of the past studies we can predict the possible side effects. If the abnormalities in the lab investigations are observed in the past studies we can say it is due to drug otherwise we need to investigate the cause of the abnormalities.

Thanks&regards
KK

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,669 registered users;
94 visitors (0 registered, 94 guests [including 59 identified bots]).
Forum time: 14:11 CEST (Europe/Vienna)

Don’t undertake a project
unless it’s manifestly important
and nearly impossible.    Edwin H. Land

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5